Patanase olopatadine hydrochloride regulatory update

ACL withdrew an application to extend marketing authorization of 6 mg/ml Opatanol nasal spray to treat symptoms of seasonal and perennial allergic rhinitis due to "marketing strategy" reasons. The ap...